{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:24:35Z","timestamp":1791887075496,"version":"4.3.4"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Strategic Priority Research Program of the Chinese Academy of Sciences","award":["XDB0830300"],"award-info":[{"award-number":["XDB0830300"]}]},{"name":"Sichuan Science and Technology Program","award":["2024NSFJQ0059 and 2025ZNSFSC0582"],"award-info":[{"award-number":["2024NSFJQ0059 and 2025ZNSFSC0582"]}]},{"name":"Joint Innovation Fund of Health Commission of Chengdu and Chengdu University of Traditional Chinese Medicine","award":["WXLH202402005, WXLH202403091 and WXLH202402008"],"award-info":[{"award-number":["WXLH202402005, WXLH202403091 and WXLH202402008"]}]},{"name":"2022 \u201cTianfu Qingcheng Plan\u201d Tianfu Science and Technology Leading Talents Project","award":["Chuan Qingcheng No. 1090"],"award-info":[{"award-number":["Chuan Qingcheng No. 1090"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2024MD763923"],"award-info":[{"award-number":["2024MD763923"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>High altitude pulmonary hypertension (HAPH) is a public health issue in high-altitude regions, characterized by increased pulmonary artery pressure, pulmonary vascular remodeling, and right heart failure, leading to the high incidence rate and high mortality. Current therapies can alleviate patient symptoms but provide limited control over disease progression. Immune regulation has gained recognition as a central driver of HAPH. Among immune cells, macrophages, as key immune regulators in the lung, orchestrate HAPH pathogenesis through recruitment, M1\/M2 polarization, inflammatory activation, metabolic reprogramming, and crosstalk with pulmonary vascular cells. Targeting macrophages has emerged as a promising therapeutic strategy. Nanoplatforms provide powerful tools to enable precise targeting and functional modulation of macrophages in HAPH, as nanoplatforms such as liposomes, polymeric nanoparticles, and exosomes enable targeted delivery and controlled release, thereby facilitating precise regulation of the pulmonary immune microenvironment, including both macrophages and pulmonary vascular cells. Recent advances in nanoplatforms have enabled the development of macrophage focused precision interventions. In this review, we first outline the pathogenic roles of macrophages in the development and progression of HAPH. We then summarize the therapeutic potential of nanoplatform-based approaches in HAPH, with a particular focus on emerging nanomaterial-based strategies that enable targeted modulation of macrophage function. We argue that nanoplatform assisted macrophage immunotherapy holds strong potential to move HAPH treatment from symptomatic management toward mechanistic and precision interventions.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12951-026-04317-1","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:36:55Z","timestamp":1775198215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["From nanotechnology to immunomodulation: emerging strategies targeting macrophages in high altitude pulmonary hypertension"],"prefix":"10.1186","volume":"24","author":[{"given":"Yi","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijie","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuantao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"4317_CR1","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43:3618\u2013731.","journal-title":"Eur Heart J"},{"key":"4317_CR2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/ehjqcco\/qcaf009","volume":"11","author":"K Liu","year":"2025","unstructured":"Liu K, Zeng Y, Wang H, Yang H, Liu L, Chen X, et al. Global, regional, and national burden of pulmonary arterial hypertension and related heart failure from 1990 to 2021, with predictions to 2050: insights from the global burden of disease study 2021. Eur Heart J Qual Care Clin Outcomes. 2025;11:969\u201380.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"4317_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/MCP.0000000000001092","volume":"30","author":"A Titz","year":"2024","unstructured":"Titz A, Hoyos R, Ulrich S. Pulmonary vascular diseases at high altitude - is it safe to live in the mountains? Curr Opin Pulm Med. 2024;30:459\u201363.","journal-title":"Curr Opin Pulm Med"},{"key":"4317_CR4","doi-asserted-by":"publisher","first-page":"e2102463118","DOI":"10.1073\/pnas.2102463118","volume":"118","author":"JC Tremblay","year":"2021","unstructured":"Tremblay JC, Ainslie PN. Global and country-level estimates of human population at high altitude. Proc Natl Acad Sci U S A. 2021;118:e2102463118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4317_CR5","doi-asserted-by":"publisher","first-page":"1902474","DOI":"10.1183\/13993003.02474-2019","volume":"56","author":"M Lichtblau","year":"2020","unstructured":"Lichtblau M, Saxer S, Furian M, Mayer L, Bader PR, Scheiwiller PM, et al. Cardiac function and pulmonary hypertension in Central Asian highlanders at 3250m. Eur Respir J. 2020;56:1902474.","journal-title":"Eur Respir J"},{"key":"4317_CR6","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/s41467-023-37527-4","volume":"14","author":"X Wu","year":"2023","unstructured":"Wu X, He Y, Chen Z, He Z, Yan Y, He Y, et al. Single-cell analysis of peripheral blood from high-altitude pulmonary hypertension patients identifies a distinct monocyte phenotype. Nat Commun. 2023;14:1820.","journal-title":"Nat Commun"},{"key":"4317_CR7","doi-asserted-by":"publisher","first-page":"S1817","DOI":"10.21037\/jtd.2019.08.60","volume":"11","author":"Z Taimeh","year":"2019","unstructured":"Taimeh Z. Assessment and treatment of the failing right heart: considerations for transplantation referral. J Thorac Dis. 2019;11:S1817\u201320.","journal-title":"J Thorac Dis"},{"key":"4317_CR8","doi-asserted-by":"publisher","first-page":"e202506505","DOI":"10.1002\/anie.202506505","volume":"64","author":"Q Ding","year":"2025","unstructured":"Ding Q, Ding L, Xiang C, Li C, Kim E, Yoon C, et al. pH-responsive AIE photosensitizers for enhanced antibacterial therapy. Angew Chem Int Ed Engl. 2025;64:e202506505.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4317_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/1872210517666230721123453","volume":"19","author":"I Sharma","year":"2025","unstructured":"Sharma I, Bhardwaj S, Karwasra R, Kaushik D, Sharma S. The emergence of nanotechnology in the prognosis and treatment of myocardial infarctions. Recent Pat Nanotechnol. 2025;19:35\u201355.","journal-title":"Recent Pat Nanotechnol"},{"key":"4317_CR10","doi-asserted-by":"publisher","first-page":"e202509183","DOI":"10.1002\/anie.202509183","volume":"64","author":"Q Ding","year":"2025","unstructured":"Ding Q, Wang B, Zhan Z, Jangili P, Chen J, Mengji R, et al. Mitosiege-driven catalase collapse: a gsh-responsive, mitochondria-targeted cof prodrug for amplified chemodynamic therapy. Angew Chem Int Ed Engl. 2025;64:e202509183.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4317_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2025.08.034","author":"P Zhao","year":"2025","unstructured":"Zhao P, Wang M, Liu Z, Zhang M, Cai Z, Zhang B, et al. Advances in biomimetic nano delivery systems for pulmonary hypertension therapy. Acta Biomater. 2025. https:\/\/doi.org\/10.1016\/j.actbio.2025.08.034.","journal-title":"Acta Biomater"},{"key":"4317_CR12","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1007\/s11426-025-2889-2","volume":"68","author":"Q Ding","year":"2025","unstructured":"Ding Q, Luo Y, Wu H, Tao J, Zhang Y, Yin G, et al. Poly(lactic-co-glycolic acid) nanomedicine for inflammatory bowel disease: targeted delivery and integrated diagnostics toward precision treatment. Sci China Chem. 2025;68:5451\u201382.","journal-title":"Sci China Chem"},{"key":"4317_CR13","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.2174\/1386207326666230130093325","volume":"26","author":"C Li","year":"2023","unstructured":"Li C, Xia J, Yiminniyaze R, Dong L, Li S. Hub genes and immune cell infiltration in hypoxia-induced pulmonary hypertension: bioinformatics analysis and in vivo validation. Comb Chem High Throughput Screen. 2023;26:2085\u201397.","journal-title":"Comb Chem High Throughput Screen"},{"key":"4317_CR14","doi-asserted-by":"publisher","first-page":"2401095","DOI":"10.1183\/13993003.01095-2024","volume":"64","author":"C Guignabert","year":"2024","unstructured":"Guignabert C, Aman J, Bonnet S, Dorfm\u00fcller P, Olschewski AJ, Pullamsetti S, et al. Pathology and pathobiology of pulmonary hypertension: current insights and future directions. Eur Respir J. 2024;64:2401095.","journal-title":"Eur Respir J"},{"key":"4317_CR15","doi-asserted-by":"publisher","first-page":"e000137","DOI":"10.1136\/bmjmed-2022-000137","volume":"2","author":"S Bousseau","year":"2023","unstructured":"Bousseau S, Sobrano Fais R, Gu S, Frump A, Lahm T. Pathophysiology and new advances in pulmonary hypertension. BMJ Med. 2023;2:e000137.","journal-title":"BMJ Med"},{"key":"4317_CR16","doi-asserted-by":"publisher","first-page":"e70024","DOI":"10.14814\/phy2.70024","volume":"12","author":"K Pham","year":"2024","unstructured":"Pham K, Vargas A, Frost S, Shah S, Heinrich EC. Changes in immune cell populations during acclimatization to high altitude. Physiol Rep. 2024;12:e70024.","journal-title":"Physiol Rep"},{"key":"4317_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12931-024-02772-8","volume":"25","author":"Y Zuo","year":"2024","unstructured":"Zuo Y, Li B, Gao M, Xiong R, He R, Li N, et al. Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension. Respir Res. 2024;25:147.","journal-title":"Respir Res"},{"key":"4317_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01902148.2022.2148016","volume":"49","author":"G Cai","year":"2023","unstructured":"Cai G, Zhang Y, Wang X, Li S, Cheng Y, Huang X. Comparison of hypoxia-induced pulmonary hypertension rat models caused by different hypoxia protocols. Exp Lung Res. 2023;49:1\u201311.","journal-title":"Exp Lung Res"},{"key":"4317_CR19","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.4049\/jimmunol.0904021","volume":"185","author":"K Yamaji-Kegan","year":"2010","unstructured":"Yamaji-Kegan K, Su Q, Angelini DJ, Myers AC, Cheadle C, Johns RA. Hypoxia-induced mitogenic factor (HIMF\/FIZZ1\/RELMalpha) increases lung inflammation and activates pulmonary microvascular endothelial cells via an IL-4-dependent mechanism. J Immunol. 2010;185:5539\u201348.","journal-title":"J Immunol"},{"key":"4317_CR20","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/bph.15339","volume":"178","author":"L Wang","year":"2021","unstructured":"Wang L, Zhang X, Cao Y, Ma Q, Mao X, Xu J, et al. Mice with a specific deficiency of Pfkfb3 in myeloid cells are protected from hypoxia-induced pulmonary hypertension. Br J Pharmacol. 2021;178:1055\u201372.","journal-title":"Br J Pharmacol"},{"key":"4317_CR21","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.4049\/jimmunol.1900535","volume":"203","author":"Q Lin","year":"2019","unstructured":"Lin Q, Fan C, Skinner JT, Hunter EN, Macdonald AA, Illei PB, et al. RELM\u03b1 licenses macrophages for damage-associated molecular pattern activation to instigate pulmonary vascular remodeling. J Immunol. 2019;203:2862\u201371.","journal-title":"J Immunol"},{"key":"4317_CR22","doi-asserted-by":"publisher","first-page":"5398157","DOI":"10.1155\/2022\/5398157","volume":"2022","author":"X Mao","year":"2022","unstructured":"Mao X, Li Y, Yang R, Wei J, Zhao Z, Zhang T, et al. Single-cell RNA-sequencing reveals the active involvement of macrophage polarizations in pulmonary hypertension. Dis Markers. 2022;2022:5398157.","journal-title":"Dis Markers"},{"key":"4317_CR23","first-page":"e326235","volume":"138","author":"Y Kim","year":"2025","unstructured":"Kim Y, Maroli G, Woodcock CC, Kim H, Liu Y, Klouda T, et al. Deficiency of smooth muscle ADAR1 exacerbates vascular remodeling and pulmonary hypertension. Circ Res. 2025;138:e326235.","journal-title":"Circ Res"},{"key":"4317_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.125.25832","author":"J Hao","year":"2026","unstructured":"Hao J, Fang G, Li X, Wang T, Peng K, Liu J, et al. Targeting macrophage crosstalk to PASMC by blunting inflammatory phenotype via serpinb1 protects against hypoxia-induced pulmonary hypertension. Hypertension. 2026. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.125.25832.","journal-title":"Hypertension"},{"key":"4317_CR25","doi-asserted-by":"publisher","first-page":"1374506","DOI":"10.3389\/fimmu.2024.1374506","volume":"15","author":"H Zhao","year":"2024","unstructured":"Zhao H, Song J, Li X, Xia Z, Wang Q, Fu J, et al. The role of immune cells and inflammation in pulmonary hypertension: mechanisms and implications. Front Immunol. 2024;15:1374506.","journal-title":"Front Immunol"},{"key":"4317_CR26","doi-asserted-by":"publisher","first-page":"7007","DOI":"10.1007\/s12274-022-5310-6","volume":"16","author":"SY Wang","year":"2023","unstructured":"Wang SY, Chen QH, Zhao TJ, Ai KL, Hu CP. Nanomedicine-based treatment: an emerging therapeutical strategy for pulmonary hypertension. Nano Res. 2023;16:7007\u201329.","journal-title":"Nano Res"},{"key":"4317_CR27","doi-asserted-by":"publisher","first-page":"e202505911","DOI":"10.1002\/anie.202505911","volume":"64","author":"Q Ding","year":"2025","unstructured":"Ding Q, Liu H, Yan L, Chen L, Chen Y, Kim JS, et al. Engineering a multifunctional nanozyme platform for synergistic melanoma therapy: integrating enzyme activity, immune activation, and low-temperature photothermal effects. Angew Chem Int Ed Engl. 2025;64:e202505911.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4317_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-023-00486-7","volume":"10","author":"A Mocumbi","year":"2024","unstructured":"Mocumbi A, Humbert M, Saxena A, Jing ZC, Sliwa K, Thienemann F, et al. Pulmonary hypertension. Nat Rev Dis Primers. 2024;10:1.","journal-title":"Nat Rev Dis Primers"},{"key":"4317_CR29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S2213-2600(23)00259-X","volume":"11","author":"KM Olsson","year":"2023","unstructured":"Olsson KM, Corte TJ, Kamp JC, Montani D, Nathan SD, Neubert L, et al. Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management. Lancet Respir Med. 2023;11:820\u201335.","journal-title":"Lancet Respir Med"},{"key":"4317_CR30","doi-asserted-by":"publisher","first-page":"e70134","DOI":"10.1002\/mco2.70134","volume":"6","author":"J Adu-Amankwaah","year":"2025","unstructured":"Adu-Amankwaah J, You Q, Liu X, Jiang J, Yang D, Liu K, et al. Pulmonary hypertension: molecular mechanisms and clinical studies. MedComm. 2025;6:e70134.","journal-title":"MedComm"},{"key":"4317_CR31","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.chest.2023.03.029","volume":"164","author":"J Yang","year":"2023","unstructured":"Yang J, Madani MM, Mahmud E, Kim NH. Evaluation and management of chronic thromboembolic pulmonary hypertension. Chest. 2023;164:490\u2013502.","journal-title":"Chest"},{"key":"4317_CR32","doi-asserted-by":"publisher","first-page":"106095","DOI":"10.1016\/j.biocel.2021.106095","volume":"141","author":"EM Melo","year":"2021","unstructured":"Melo EM, Oliveira VLS, Boff D, Galv\u00e3o I. Pulmonary macrophages and their different roles in health and disease. Int J Biochem Cell Biol. 2021;141:106095.","journal-title":"Int J Biochem Cell Biol"},{"key":"4317_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.imbio.2017.11.001","volume":"223","author":"S Arora","year":"2018","unstructured":"Arora S, Dev K, Agarwal B, Das P, Syed MA. Macrophages: their role, activation and polarization in pulmonary diseases. Immunobiology. 2018;223:383\u201396.","journal-title":"Immunobiology"},{"key":"4317_CR34","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.immuni.2022.08.010","volume":"55","author":"H Aegerter","year":"2022","unstructured":"Aegerter H, Lambrecht BN, Jakubzick CV. Biology of lung macrophages in health and disease. Immunity. 2022;55:1564\u201380.","journal-title":"Immunity"},{"key":"4317_CR35","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1136\/thoraxjnl-2015-207020","volume":"70","author":"AJ Byrne","year":"2015","unstructured":"Byrne AJ, Mathie SA, Gregory LG, Lloyd CM. Pulmonary macrophages: key players in the innate defence of the airways. Thorax. 2015;70:1189\u201396.","journal-title":"Thorax"},{"key":"4317_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nature12902","volume":"506","author":"K Westphalen","year":"2014","unstructured":"Westphalen K, Gusarova GA, Islam MN, Subramanian M, Cohen TS, Prince AS, et al. Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. Nature. 2014;506:503\u20136.","journal-title":"Nature"},{"key":"4317_CR37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cellimm.2018.01.005","volume":"330","author":"N Joshi","year":"2018","unstructured":"Joshi N, Walter JM, Misharin AV. Alveolar macrophages. Cell Immunol. 2018;330:86\u201390.","journal-title":"Cell Immunol"},{"key":"4317_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41392-025-02124-y","volume":"10","author":"F Guan","year":"2025","unstructured":"Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y, et al. Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets. Signal Transduct Target Ther. 2025;10:93.","journal-title":"Signal Transduct Target Ther"},{"key":"4317_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1165\/rcmb.2017-0328ED","volume":"58","author":"AC McQuattie-Pimentel","year":"2018","unstructured":"McQuattie-Pimentel AC, Budinger GRS, Ballinger MN. Monocyte-derived alveolar macrophages: the dark side of lung repair? Am J Respir Cell Mol Biol. 2018;58:5\u20136.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4317_CR40","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.immuni.2013.04.004","volume":"38","author":"D Hashimoto","year":"2013","unstructured":"Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 2013;38:792\u2013804.","journal-title":"Immunity"},{"key":"4317_CR41","doi-asserted-by":"publisher","first-page":"292","DOI":"10.14348\/molcells.2021.0058","volume":"44","author":"YD Woo","year":"2021","unstructured":"Woo YD, Jeong D, Chung DH. Development and functions of alveolar macrophages. Mol Cells. 2021;44:292\u2013300.","journal-title":"Mol Cells"},{"key":"4317_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13567-025-01529-5","volume":"56","author":"J Tang","year":"2025","unstructured":"Tang J, Gao Y, Fu Y, Han Z, Xu P, Li X, et al. Astragaloside IV mitigates influenza-induced inflammatory responses by suppressing the Wnt\/\u03b2-catenin signalling pathway in alveolar macrophages. Vet Res. 2025;56:95.","journal-title":"Vet Res"},{"key":"4317_CR43","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1084\/jem.20162152","volume":"214","author":"AV Misharin","year":"2017","unstructured":"Misharin AV, Morales-Nebreda L, Reyfman PA, Cuda CM, Walter JM, McQuattie-Pimentel AC, et al. Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J Exp Med. 2017;214:2387\u2013404.","journal-title":"J Exp Med"},{"key":"4317_CR44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1165\/rcmb.2023-0426TR","volume":"71","author":"L Song","year":"2024","unstructured":"Song L, Li K, Chen H, Xie L. Cell cross-talk in alveolar microenvironment: from lung injury to fibrosis. Am J Respir Cell Mol Biol. 2024;71:30\u201342.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4317_CR45","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1164\/rccm.201911-2105OC","volume":"201","author":"PS Hume","year":"2020","unstructured":"Hume PS, Gibbings SL, Jakubzick CV, Tuder RM, Curran-Everett D, Henson PM, et al. Localization of macrophages in the human lung via design-based stereology. Am J Respir Crit Care Med. 2020;201:1209\u201317.","journal-title":"Am J Respir Crit Care Med"},{"key":"4317_CR46","doi-asserted-by":"publisher","first-page":"5160794","DOI":"10.1155\/2018\/5160794","volume":"2018","author":"J Schyns","year":"2018","unstructured":"Schyns J, Bureau F, Marichal T. Lung interstitial macrophages: past, present, and future. J Immunol Res. 2018;2018:5160794.","journal-title":"J Immunol Res"},{"key":"4317_CR47","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1172\/JCI39717","volume":"119","author":"D Bedoret","year":"2009","unstructured":"Bedoret D, Wallemacq H, Marichal T, Desmet C, Quesada Calvo F, Henry E, et al. Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J Clin Invest. 2009;119:3723\u201338.","journal-title":"J Clin Invest"},{"key":"4317_CR48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41385-021-00480-w","volume":"15","author":"CC Bain","year":"2022","unstructured":"Bain CC, MacDonald AS. The impact of the lung environment on macrophage development, activation and function: diversity in the face of adversity. Mucosal Immunol. 2022;15:223\u201334.","journal-title":"Mucosal Immunol"},{"key":"4317_CR49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1465-9921-10-6","volume":"10","author":"L Savale","year":"2009","unstructured":"Savale L, Tu L, Rideau D, Izziki M, Maitre B, Adnot S, et al. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir Res. 2009;10:6.","journal-title":"Respir Res"},{"key":"4317_CR50","doi-asserted-by":"publisher","first-page":"L1159","DOI":"10.1152\/ajplung.00168.2006","volume":"291","author":"K Yamaji-Kegan","year":"2006","unstructured":"Yamaji-Kegan K, Su Q, Angelini DJ, Champion HC, Johns RA. Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. Am J Physiol Lung Cell Mol Physiol. 2006;291:L1159\u201368.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4317_CR51","doi-asserted-by":"publisher","first-page":"1372959","DOI":"10.3389\/fimmu.2024.1372959","volume":"15","author":"S Kumar","year":"2024","unstructured":"Kumar S, Mickael C, Kumar R, Prasad RR, Campbell NV, Zhang H, et al. Single cell transcriptomic analyses reveal diverse and dynamic changes of distinct populations of lung interstitial macrophages in hypoxia-induced pulmonary hypertension. Front Immunol. 2024;15:1372959.","journal-title":"Front Immunol"},{"key":"4317_CR52","doi-asserted-by":"publisher","first-page":"106976","DOI":"10.1016\/j.vph.2022.106976","volume":"144","author":"R Hashimoto","year":"2022","unstructured":"Hashimoto R, Gupte SA. G6PD is a critical enabler of hypoxia-induced accumulation of macrophages and platelets in mice lungs and contributor to lung inflammation. Vascul Pharmacol. 2022;144:106976.","journal-title":"Vascul Pharmacol"},{"key":"4317_CR53","doi-asserted-by":"publisher","first-page":"113028","DOI":"10.1016\/j.intimp.2024.113028","volume":"142","author":"H Li","year":"2024","unstructured":"Li H, Liu Y, Zhang H, Shi X, Luo Y, Fu G, et al. Identification of potential diagnostic biomarkers and therapeutic targets in patients with hypoxia pulmonary hypertension. Int Immunopharmacol. 2024;142:113028.","journal-title":"Int Immunopharmacol"},{"key":"4317_CR54","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.18632\/aging.204690","volume":"15","author":"H Ma","year":"2023","unstructured":"Ma H, Yu Y, Mo L, Chen Q, Dong H, Xu Y, et al. Exosomal miR-663b from M1 macrophages promotes pulmonary artery vascular smooth muscle cell dysfunction through inhibiting the AMPK\/Sirt1 axis. Aging. 2023;15:3549\u201371.","journal-title":"Aging"},{"key":"4317_CR55","doi-asserted-by":"publisher","first-page":"e14212","DOI":"10.1111\/apha.14212","volume":"240","author":"ASI Ahmed","year":"2024","unstructured":"Ahmed ASI, Blood AB, Zhang L. MicroRNA-210 mediates hypoxia-induced pulmonary hypertension by targeting mitochondrial bioenergetics and mtROS flux. Acta Physiol. 2024;240:e14212.","journal-title":"Acta Physiol"},{"key":"4317_CR56","doi-asserted-by":"publisher","first-page":"763","DOI":"10.33549\/physiolres.933187","volume":"65","author":"M \u017daloud\u00edkov\u00e1","year":"2016","unstructured":"\u017daloud\u00edkov\u00e1 M, Vyt\u00e1\u0161ek R, Vajnerov\u00e1 O, Hnili\u010dkov\u00e1 O, V\u00edzek M, Hampl V, et al. Depletion of alveolar macrophages attenuates hypoxic pulmonary hypertension but not hypoxia-induced increase in serum concentration of MCP-1. Physiol Res. 2016;65:763\u20138.","journal-title":"Physiol Res"},{"key":"4317_CR57","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1161\/CIRCULATIONAHA.114.010757","volume":"130","author":"V Amsellem","year":"2014","unstructured":"Amsellem V, Lipskaia L, Abid S, Poupel L, Houssaini A, Quarck R, et al. CCR5 as a treatment target in pulmonary arterial hypertension. Circulation. 2014;130:880\u201391.","journal-title":"Circulation"},{"key":"4317_CR58","doi-asserted-by":"publisher","first-page":"e0131923","DOI":"10.1371\/journal.pone.0131923","volume":"10","author":"H Nagai","year":"2015","unstructured":"Nagai H, Kuwahira I, Schwenke DO, Tsuchimochi H, Nara A, Ogura S, et al. Pulmonary macrophages attenuate hypoxic pulmonary vasoconstriction via \u03b23AR\/iNOS pathway in rats exposed to chronic intermittent hypoxia. PLoS ONE. 2015;10:e0131923.","journal-title":"PLoS ONE"},{"key":"4317_CR59","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1007\/s13346-024-01571-4","volume":"14","author":"B Tessier","year":"2024","unstructured":"Tessier B, Moine L, Peramo A, Tsapis N, Fattal E. Poly(malic acid)-budesonide nanoconjugates embedded in microparticles for lung administration. Drug Deliv Transl Res. 2024;14:2062\u201378.","journal-title":"Drug Deliv Transl Res"},{"key":"4317_CR60","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.imlet.2023.10.005","volume":"263","author":"H Liu","year":"2023","unstructured":"Liu H, Wang Y, Zhang Q, Liu C, Ma Y, Huang P, et al. Macrophage-derived inflammation promotes pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension mice. Immunol Lett. 2023;263:113\u201322.","journal-title":"Immunol Lett"},{"key":"4317_CR61","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1165\/rcmb.2016-0201OC","volume":"56","author":"V Amsellem","year":"2017","unstructured":"Amsellem V, Abid S, Poupel L, Parpaleix A, Rodero M, Gary-Bobo G, et al. Roles for the CX3CL1\/CX3CR1 and CCL2\/CCR2 chemokine systems in hypoxic pulmonary hypertension. Am J Respir Cell Mol Biol. 2017;56:597\u2013608.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4317_CR62","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12931-024-03058-9","volume":"25","author":"C Li","year":"2024","unstructured":"Li C, Liu P, Zhu H, Yang H, Zha J, Yao H, et al. T follicular helper cell is essential for M2 macrophage polarization and pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension. Respir Res. 2024;25:428.","journal-title":"Respir Res"},{"key":"4317_CR63","doi-asserted-by":"publisher","first-page":"116864","DOI":"10.1016\/j.lfs.2019.116864","volume":"236","author":"M \u017daloud\u00edkov\u00e1","year":"2019","unstructured":"\u017daloud\u00edkov\u00e1 M, Vyt\u00e1\u0161ek R, Ra\u0161kov\u00e1 M, V\u00edzek M, Uhl\u00edk J, Hampl V. The effect of exposure to hypoxia on superoxide formation by alveolar macrophages is indirect. Life Sci. 2019;236:116864.","journal-title":"Life Sci"},{"key":"4317_CR64","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","volume":"20","author":"HJ Forman","year":"2021","unstructured":"Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021;20:689\u2013709.","journal-title":"Nat Rev Drug Discov"},{"key":"4317_CR65","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41584-025-01279-w","volume":"21","author":"M Cutolo","year":"2025","unstructured":"Cutolo M, Soldano S, Smith V, Gotelli E, Hysa E. Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases. Nat Rev Rheumatol. 2025;21:546\u201365.","journal-title":"Nat Rev Rheumatol"},{"key":"4317_CR66","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1080\/17435390.2021.1905098","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang X, Luo M, Zhang J, Yao Z, Zhu J, Yang S, et al. Carbon nanotubes promote alveolar macrophages toward M2 polarization mediated epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation. Nanotoxicology. 2021;15:588\u2013604.","journal-title":"Nanotoxicology"},{"key":"4317_CR67","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1161\/HYPERTENSIONAHA.124.23542","volume":"82","author":"D Lin","year":"2025","unstructured":"Lin D, Hu L, Wei D, Li Y, Yu Y, Wang Q, et al. Peli1 deficiency in macrophages attenuates pulmonary hypertension by enhancing Foxp1-mediated transcriptional inhibition of IL-6. Hypertension. 2025;82:445\u201359.","journal-title":"Hypertension"},{"key":"4317_CR68","doi-asserted-by":"publisher","first-page":"102638","DOI":"10.1016\/j.redox.2023.102638","volume":"61","author":"L Hu","year":"2023","unstructured":"Hu L, Yu Y, Shen Y, Huang H, Lin D, Wang K, et al. Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages. Redox Biol. 2023;61:102638.","journal-title":"Redox Biol"},{"key":"4317_CR69","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1161\/CIRCULATIONAHA.122.059435","volume":"146","author":"A Yaku","year":"2022","unstructured":"Yaku A, Inagaki T, Asano R, Okazawa M, Mori H, Sato A, et al. Regnase-1 prevents pulmonary arterial hypertension through mRNA degradation of interleukin-6 and platelet-derived growth factor in alveolar macrophages. Circulation. 2022;146:1006\u201322.","journal-title":"Circulation"},{"key":"4317_CR70","doi-asserted-by":"publisher","first-page":"114511","DOI":"10.1016\/j.ejpb.2024.114511","volume":"204","author":"Y Yao","year":"2024","unstructured":"Yao Y, Fan S, Fan Y, Shen X, Chai X, Pi J, et al. Intratracheal delivery of macrophage targeted celastrol-loaded PLGA nanoparticles for enhanced anti-inflammatory efficacy in acute lung injury mice. Eur J Pharm Biopharm. 2024;204:114511.","journal-title":"Eur J Pharm Biopharm"},{"key":"4317_CR71","doi-asserted-by":"publisher","first-page":"1111123","DOI":"10.3389\/fimmu.2023.1111123","volume":"14","author":"JS Erdem","year":"2023","unstructured":"Erdem JS, Z\u00e1vodn\u00e1 T, Ervik TK, Skare \u00d8, Hron T, Anmarkrud KH, et al. High aspect ratio nanomaterial-induced macrophage polarization is mediated by changes in miRNA levels. Front Immunol. 2023;14:1111123.","journal-title":"Front Immunol"},{"key":"4317_CR72","doi-asserted-by":"publisher","first-page":"1534009","DOI":"10.3389\/fimmu.2025.1534009","volume":"16","author":"B Sun","year":"2025","unstructured":"Sun B, Long Y, Xu G, Chen J, Wu G, Liu B, et al. Acute hypoxia modulate macrophage phenotype accompanied with transcriptome re-programming and metabolic re-modeling. Front Immunol. 2025;16:1534009.","journal-title":"Front Immunol"},{"key":"4317_CR73","doi-asserted-by":"publisher","first-page":"e77457","DOI":"10.7554\/eLife.77457","volume":"11","author":"PS Woods","year":"2022","unstructured":"Woods PS, Kimmig LM, Sun KA, Meliton AY, Shamaa OR, Tian Y, et al. HIF-1\u03b1 induces glycolytic reprograming in tissue-resident alveolar macrophages to promote cell survival during acute lung injury. Elife. 2022;11:e77457.","journal-title":"Elife"},{"key":"4317_CR74","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1165\/rcmb.2019-0244OC","volume":"62","author":"PS Woods","year":"2020","unstructured":"Woods PS, Kimmig LM, Meliton AY, Sun KA, Tian Y, O\u2019Leary EM, et al. Tissue-resident alveolar macrophages do not rely on glycolysis for LPS-induced inflammation. Am J Respir Cell Mol Biol. 2020;62:243\u201355.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4317_CR75","doi-asserted-by":"publisher","first-page":"e139067","DOI":"10.1172\/jci.insight.139067","volume":"6","author":"A Ntokou","year":"2021","unstructured":"Ntokou A, Dave JM, Kauffman AC, Sauler M, Ryu C, Hwa J, et al. Macrophage-derived PDGF-B induces muscularization in murine and human pulmonary hypertension. JCI Insight. 2021;6:e139067.","journal-title":"JCI Insight"},{"key":"4317_CR76","doi-asserted-by":"publisher","first-page":"492","DOI":"10.4049\/jimmunol.1501845","volume":"198","author":"W Deng","year":"2017","unstructured":"Deng W, Yang J, Lin X, Shin J, Gao J, Zhong X. Essential role of mTORC1 in self-renewal of murine alveolar macrophages. J Immunol. 2017;198:492\u2013504.","journal-title":"J Immunol"},{"key":"4317_CR77","doi-asserted-by":"publisher","first-page":"913","DOI":"10.4049\/jimmunol.2100230","volume":"207","author":"SL Collins","year":"2021","unstructured":"Collins SL, Oh MH, Sun IH, Chan-Li Y, Zhao L, Powell JD, et al. mTORC1 signaling regulates proinflammatory macrophage function and metabolism. J Immunol. 2021;207:913\u201322.","journal-title":"J Immunol"},{"key":"4317_CR78","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.4049\/jimmunol.1601692","volume":"198","author":"SC Pugliese","year":"2017","unstructured":"Pugliese SC, Kumar S, Janssen WJ, Graham BB, Frid MG, Riddle SR, et al. A Time- and compartment-specific activation of lung macrophages in hypoxic pulmonary hypertension. J Immunol. 2017;198:4802\u201312.","journal-title":"J Immunol"},{"key":"4317_CR79","first-page":"246","volume":"16","author":"T Meng","year":"2024","unstructured":"Meng T, He D, Han Z, Shi R, Wang Y, Ren B, et al. Nanomaterial-based repurposing of macrophage metabolism and its applications. Nanomicro Lett. 2024;16:246.","journal-title":"Nanomicro Lett"},{"key":"4317_CR80","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2353\/ajpath.2006.050599","volume":"168","author":"MG Frid","year":"2006","unstructured":"Frid MG, Brunetti JA, Burke DL, Carpenter TC, Davie NJ, Reeves JT, et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte\/macrophage lineage. Am J Pathol. 2006;168:659\u201369.","journal-title":"Am J Pathol"},{"key":"4317_CR81","doi-asserted-by":"publisher","first-page":"e100310","DOI":"10.1371\/journal.pone.0100310","volume":"9","author":"B Gore","year":"2014","unstructured":"Gore B, Izikki M, Mercier O, Dewachter L, Fadel E, Humbert M, et al. Key role of the endothelial TGF-\u03b2\/ALK1\/endoglin signaling pathway in humans and rodents pulmonary hypertension. PLoS ONE. 2014;9:e100310.","journal-title":"PLoS ONE"},{"key":"4317_CR82","doi-asserted-by":"publisher","first-page":"731","DOI":"10.14336\/AD.2018.1001","volume":"10","author":"T Li","year":"2019","unstructured":"Li T, Zha L, Luo H, Li S, Zhao L, He J, et al. Galectin-3 Mediates endothelial-to-mesenchymal transition in pulmonary arterial hypertension. Aging Dis. 2019;10:731\u201345.","journal-title":"Aging Dis"},{"key":"4317_CR83","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1161\/CIRCULATIONAHA.122.061900","volume":"146","author":"W Zhou","year":"2022","unstructured":"Zhou W, Liu K, Zeng L, He J, Gao X, Gu X, et al. Targeting VEGF-A\/VEGFR2 Y949 signaling-mediated vascular permeability alleviates hypoxic pulmonary hypertension. Circulation. 2022;146:1855\u201381.","journal-title":"Circulation"},{"key":"4317_CR84","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1253\/circj.CJ-13-1586","volume":"78","author":"S Nergui","year":"2014","unstructured":"Nergui S, Fukumoto Y, Do EZ, Nakajima S, Shimizu T, Ikeda S, et al. Role of endothelial nitric oxide synthase and collagen metabolism in right ventricular remodeling due to pulmonary hypertension. Circ J. 2014;78:1465\u201374.","journal-title":"Circ J"},{"key":"4317_CR85","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1161\/ATVBAHA.113.301335","volume":"33","author":"J Li","year":"2013","unstructured":"Li J, Rao J, Liu Y, Cao Y, Zhang Y, Zhang Q, et al. 15-Lipoxygenase promotes chronic hypoxia-induced pulmonary artery inflammation via positive interaction with nuclear factor-\u03baB. Arterioscler Thromb Vasc Biol. 2013;33:971\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4317_CR86","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1084\/jem.20111741","volume":"211","author":"H Sawada","year":"2014","unstructured":"Sawada H, Saito T, Nickel NP, Alastalo TP, Glotzbach JP, Chan R, et al. Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension. J Exp Med. 2014;211:263\u201380.","journal-title":"J Exp Med"},{"key":"4317_CR87","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1183\/13993003.01448-2015","volume":"48","author":"A Parpaleix","year":"2016","unstructured":"Parpaleix A, Amsellem V, Houssaini A, Abid S, Breau M, Marcos E, et al. Role of interleukin-1 receptor 1\/MyD88 signalling in the development and progression of pulmonary hypertension. Eur Respir J. 2016;48:470\u201383.","journal-title":"Eur Respir J"},{"key":"4317_CR88","doi-asserted-by":"publisher","first-page":"e000188","DOI":"10.1161\/JAHA.113.000188","volume":"2","author":"H Horita","year":"2013","unstructured":"Horita H, Furgeson SB, Ostriker A, Olszewski KA, Sullivan T, Villegas LR, et al. Selective inactivation of PTEN in smooth muscle cells synergizes with hypoxia to induce severe pulmonary hypertension. J Am Heart Assoc. 2013;2:e000188.","journal-title":"J Am Heart Assoc"},{"key":"4317_CR89","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.4049\/jimmunol.1100479","volume":"187","author":"M Li","year":"2011","unstructured":"Li M, Riddle SR, Frid MG, El Kasmi KC, McKinsey TA, Sokol RJ, et al. Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension. J Immunol. 2011;187:2711\u201322.","journal-title":"J Immunol"},{"key":"4317_CR90","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1161\/CIRCULATIONAHA.116.023171","volume":"134","author":"M Li","year":"2016","unstructured":"Li M, Riddle S, Zhang H, D\u2019Alessandro A, Flockton A, Serkova NJ, et al. Metabolic reprogramming regulates the proliferative and inflammatory phenotype of adventitial fibroblasts in pulmonary hypertension through the transcriptional corepressor c-terminal binding protein-1. Circulation. 2016;134:1105\u201321.","journal-title":"Circulation"},{"key":"4317_CR91","doi-asserted-by":"publisher","first-page":"L413","DOI":"10.1152\/ajplung.00519.2020","volume":"320","author":"C Delaney","year":"2021","unstructured":"Delaney C, Davizon-Castillo P, Allawzi A, Posey J, Gandjeva A, Neeves K, et al. Platelet activation contributes to hypoxia-induced inflammation. Am J Physiol Lung Cell Mol Physiol. 2021;320:L413\u201321.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4317_CR92","doi-asserted-by":"publisher","first-page":"e70015","DOI":"10.1096\/fj.202400338RR","volume":"38","author":"C Mickael","year":"2024","unstructured":"Mickael C, Sanders LA, Lee MH, Kumar R, Fonseca-Balladares D, Gandjeva A, et al. Classical dendritic cells contribute to hypoxia-induced pulmonary hypertension. FASEB J. 2024;38:e70015.","journal-title":"FASEB J"},{"key":"4317_CR93","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.4049\/jimmunol.1701287","volume":"200","author":"J Florentin","year":"2018","unstructured":"Florentin J, Coppin E, Vasamsetti SB, Zhao J, Tai YY, Tang Y, et al. Inflammatory macrophage expansion in pulmonary hypertension depends upon mobilization of blood-borne monocytes. J Immunol. 2018;200:3612\u201325.","journal-title":"J Immunol"},{"key":"4317_CR94","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.4049\/jimmunol.1900239","volume":"204","author":"YA Yu","year":"2020","unstructured":"Yu YA, Malakhau Y, Yu CA, Phelan SJ, Cumming RI, Kan MJ, et al. Nonclassical monocytes sense hypoxia, regulate pulmonary vascular remodeling, and promote pulmonary hypertension. J Immunol. 2020;204:1474\u201385.","journal-title":"J Immunol"},{"key":"4317_CR95","doi-asserted-by":"publisher","first-page":"H293","DOI":"10.1152\/ajpheart.00785.2016","volume":"313","author":"R Hashimoto","year":"2017","unstructured":"Hashimoto R, Joshi SR, Jiang H, Capdevila JH, McMurtry IF, Laniado Schwartzman M, et al. Cyp2c44 gene disruption is associated with increased hematopoietic stem cells: implication in chronic hypoxia-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2017;313:H293\u2013303.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4317_CR96","doi-asserted-by":"publisher","first-page":"100653","DOI":"10.1016\/j.mtbio.2023.100653","volume":"20","author":"Z Li","year":"2023","unstructured":"Li Z, Zhang Q, Xiang J, Zhao M, Meng Y, Hu X, et al. Novel strategy of combined interstitial macrophage depletion with intravenous targeted therapy to ameliorate pulmonary fibrosis. Mater Today Bio. 2023;20:100653.","journal-title":"Mater Today Bio"},{"key":"4317_CR97","doi-asserted-by":"publisher","first-page":"L416","DOI":"10.1152\/ajplung.00068.2020","volume":"321","author":"M Nakahara","year":"2021","unstructured":"Nakahara M, Ito H, Skinner JT, Lin Q, Tamosiuniene R, Nicolls MR, et al. The inflammatory role of dysregulated IRS2 in pulmonary vascular remodeling under hypoxic conditions. Am J Physiol Lung Cell Mol Physiol. 2021;321:L416\u201328.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4317_CR98","doi-asserted-by":"publisher","first-page":"177152","DOI":"10.1016\/j.ejphar.2024.177152","volume":"986","author":"G Lu","year":"2025","unstructured":"Lu G, Du R, Lu L, Wang Q, Zhang M, Gu X, et al. Macrophage-specific \u03ba-OR knockout exacerbates inflammation in hypoxic pulmonary hypertension. Eur J Pharmacol. 2025;986:177152.","journal-title":"Eur J Pharmacol"},{"key":"4317_CR99","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.lfs.2013.12.215","volume":"118","author":"T Van Hung","year":"2014","unstructured":"Van Hung T, Emoto N, Vignon-Zellweger N, Nakayama K, Yagi K, Suzuki Y, et al. Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin. Life Sci. 2014;118:313\u201328.","journal-title":"Life Sci"},{"key":"4317_CR100","doi-asserted-by":"publisher","first-page":"1802308","DOI":"10.1183\/13993003.02308-2018","volume":"54","author":"S Abid","year":"2019","unstructured":"Abid S, Marcos E, Parpaleix A, Amsellem V, Breau M, Houssaini A, et al. CCR2\/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension. Eur Respir J. 2019;54:1802308.","journal-title":"Eur Respir J"},{"key":"4317_CR101","doi-asserted-by":"publisher","first-page":"3013765","DOI":"10.1155\/2019\/3013765","volume":"2019","author":"X Xi","year":"2019","unstructured":"Xi X, Zhang J, Wang J, Chen Y, Zhang W, Zhang X, et al. SGK1 mediates hypoxic pulmonary hypertension through promoting macrophage infiltration and activation. Anal Cell Pathol. 2019;2019:3013765.","journal-title":"Anal Cell Pathol"},{"key":"4317_CR102","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/cvr\/cvz304","volume":"116","author":"R Kumar","year":"2020","unstructured":"Kumar R, Mickael C, Kassa B, Sanders L, Hernandez-Saavedra D, Koyanagi DE, et al. Interstitial macrophage-derived thrombospondin-1 contributes to hypoxia-induced pulmonary hypertension. Cardiovasc Res. 2020;116:2021\u201330.","journal-title":"Cardiovasc Res"},{"key":"4317_CR103","doi-asserted-by":"publisher","first-page":"e176865","DOI":"10.1172\/JCI176865","volume":"135","author":"R Kumar","year":"2025","unstructured":"Kumar R, Nolan K, Kassa B, Chanana N, Palmo T, Sharma K, et al. Monocytes and interstitial macrophages contribute to hypoxic pulmonary hypertension. J Clin Invest. 2025;135:e176865.","journal-title":"J Clin Invest"},{"key":"4317_CR104","doi-asserted-by":"publisher","first-page":"e49756","DOI":"10.1371\/journal.pone.0049756","volume":"7","author":"M Yu","year":"2012","unstructured":"Yu M, Gong D, Lim M, Arutyunyan A, Groffen J, Heisterkamp N. Lack of bcr and abr promotes hypoxia-induced pulmonary hypertension in mice. PLoS ONE. 2012;7:e49756.","journal-title":"PLoS ONE"},{"key":"4317_CR105","doi-asserted-by":"publisher","first-page":"640718","DOI":"10.3389\/fimmu.2021.640718","volume":"12","author":"M Li","year":"2021","unstructured":"Li M, Riddle S, Kumar S, Poczobutt J, McKeon BA, Frid MG, et al. Microenvironmental regulation of macrophage transcriptomic and metabolomic profiles in pulmonary hypertension. Front Immunol. 2021;12:640718.","journal-title":"Front Immunol"},{"key":"4317_CR106","doi-asserted-by":"publisher","first-page":"e148382","DOI":"10.1172\/jci.insight.148382","volume":"6","author":"S Kumar","year":"2021","unstructured":"Kumar S, Frid MG, Zhang H, Li M, Riddle S, Brown RD, et al. Complement-containing small extracellular vesicles from adventitial fibroblasts induce proinflammatory and metabolic reprogramming in macrophages. JCI Insight. 2021;6:e148382.","journal-title":"JCI Insight"},{"key":"4317_CR107","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4049\/jimmunol.1303048","volume":"193","author":"KC El Kasmi","year":"2014","unstructured":"El Kasmi KC, Pugliese SC, Riddle SR, Poth JM, Anderson AL, Frid MG, et al. Adventitial fibroblasts induce a distinct proinflammatory\/profibrotic macrophage phenotype in pulmonary hypertension. J Immunol. 2014;193:597\u2013609.","journal-title":"J Immunol"},{"key":"4317_CR108","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jconrel.2021.11.047","volume":"341","author":"C Guo","year":"2022","unstructured":"Guo C, Zhang C, Xia Z, Song B, Hu W, Cui Y, et al. Nano-designed CO donor ameliorates bleomycin-induced pulmonary fibrosis via macrophage manipulation. J Control Release. 2022;341:566\u201377.","journal-title":"J Control Release"},{"key":"4317_CR109","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.1021\/acsnano.3c09528","volume":"18","author":"J Gu","year":"2024","unstructured":"Gu J, Zhang P, Li H, Wang Y, Huang Y, Fan L, et al. Cerium-luteolin nanocomplexes in managing inflammation-related diseases by antioxidant and immunoregulation. ACS Nano. 2024;18:6229\u201342.","journal-title":"ACS Nano"},{"key":"4317_CR110","doi-asserted-by":"publisher","first-page":"e14025","DOI":"10.14814\/phy2.14025","volume":"7","author":"H Kojima","year":"2019","unstructured":"Kojima H, Tokunou T, Takahara Y, Sunagawa K, Hirooka Y, Ichiki T, et al. Hypoxia-inducible factor-1 \u03b1 deletion in myeloid lineage attenuates hypoxia-induced pulmonary hypertension. Physiol Rep. 2019;7:e14025.","journal-title":"Physiol Rep"},{"key":"4317_CR111","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1161\/ATVBAHA.115.306710","volume":"36","author":"RA Johns","year":"2016","unstructured":"Johns RA, Takimoto E, Meuchel LW, Elsaigh E, Zhang A, Heller NM, et al. Hypoxia-inducible factor 1\u03b1 is a critical downstream mediator for hypoxia-induced mitogenic Factor (FIZZ1\/RELM\u03b1)-induced pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2016;36:134\u201344.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4317_CR112","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1152\/physiolgenomics.00078.2024","volume":"56","author":"CV Lewis","year":"2024","unstructured":"Lewis CV, Garcia AM, Burciaga SD, Posey JN, Jordan M, Nguyen TN, et al. Redistribution of SOD3 expression due to R213G polymorphism affects pulmonary interstitial macrophage reprogramming in response to hypoxia. Physiol Genomics. 2024;56:776\u201390.","journal-title":"Physiol Genomics"},{"key":"4317_CR113","doi-asserted-by":"publisher","first-page":"9916","DOI":"10.3390\/ijms22189916","volume":"22","author":"V Karoor","year":"2021","unstructured":"Karoor V, Strassheim D, Sullivan T, Verin A, Umapathy NS, Dempsey EC, et al. The short-chain fatty acid butyrate attenuates pulmonary vascular remodeling and inflammation in hypoxia-induced pulmonary hypertension. Int J Mol Sci. 2021;22:9916.","journal-title":"Int J Mol Sci"},{"key":"4317_CR114","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1161\/HYPERTENSIONAHA.123.20914","volume":"80","author":"NV Pakhomov","year":"2023","unstructured":"Pakhomov NV, Kostyunina DS, Macori G, Dillon E, Brady T, Sundaramoorthy G, et al. High-soluble-fiber diet attenuates hypoxia-induced vascular remodeling and the development of hypoxic pulmonary hypertension. Hypertension. 2023;80:2372\u201385.","journal-title":"Hypertension"},{"key":"4317_CR115","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/cvr\/cvz312","volume":"116","author":"J Zhang","year":"2020","unstructured":"Zhang J, Lu X, Liu M, Fan H, Zheng H, Zhang S, et al. Melatonin inhibits inflammasome-associated activation of endothelium and macrophages attenuating pulmonary arterial hypertension. Cardiovasc Res. 2020;116:2156\u201369.","journal-title":"Cardiovasc Res"},{"key":"4317_CR116","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1165\/rcmb.2013-0063OC","volume":"51","author":"A Klinke","year":"2014","unstructured":"Klinke A, M\u00f6ller A, Pekarova M, Ravekes T, Friedrichs K, Berlin M, et al. Protective effects of 10-nitro-oleic acid in a hypoxia-induced murine model of pulmonary hypertension. Am J Respir Cell Mol Biol. 2014;51:155\u201362.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4317_CR117","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1590\/S0100-879X2012007500014","volume":"45","author":"JS Camelo Jr","year":"2012","unstructured":"Camelo JS Jr., Martins AR, Rosa E, Ramos SG, Hehre D, Bancalari E, et al. Angiotensin II type 1 receptor blockade partially attenuates hypoxia-induced pulmonary hypertension in newborn piglets: relationship with the nitrergic system. Braz J Med Biol Res. 2012;45:163\u201371.","journal-title":"Braz J Med Biol Res"},{"key":"4317_CR118","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1161\/CIRCULATIONAHA.110.978627","volume":"123","author":"E Vergadi","year":"2011","unstructured":"Vergadi E, Chang MS, Lee C, Liang OD, Liu X, Fernandez-Gonzalez A, et al. Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension. Circulation. 2011;123:1986\u201395.","journal-title":"Circulation"},{"key":"4317_CR119","doi-asserted-by":"publisher","first-page":"204589402091935","DOI":"10.1177\/2045894020919355","volume":"10","author":"T Kato","year":"2020","unstructured":"Kato T, Mitani Y, Masuya M, Maruyama J, Sawada H, Ohashi H, et al. A non-selective endothelin receptor antagonist bosentan modulates kinetics of bone marrow-derived cells in ameliorating pulmonary hypertension in mice. Pulm Circ. 2020;10:2045894020919355.","journal-title":"Pulm Circ"},{"key":"4317_CR120","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/jcmm.13026","volume":"21","author":"S Favre","year":"2017","unstructured":"Favre S, Gambini E, Nigro P, Scopece A, Bianciardi P, Caretti A, et al. Sildenafil attenuates hypoxic pulmonary remodelling by inhibiting bone marrow progenitor cells. J Cell Mol Med. 2017;21:871\u201380.","journal-title":"J Cell Mol Med"},{"key":"4317_CR121","doi-asserted-by":"publisher","first-page":"e288","DOI":"10.1161\/ATVBAHA.124.321264","volume":"44","author":"A Fernandez-Gonzalez","year":"2024","unstructured":"Fernandez-Gonzalez A, Mukhia A, Nadkarni J, Willis GR, Reis M, Zhumka K, et al. Immunoregulatory macrophages modify local pulmonary immunity and ameliorate hypoxic pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2024;44:e288\u2013303.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4317_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11426-024-2224-9","volume":"68","author":"Q Ding","year":"2025","unstructured":"Ding Q, He M, Gu M. Breaking new ground in photocatalysis: lutetium texaphyrin as a trigger for pyroptosis through biomolecular photoredox reactions. Sci China Chem. 2025;68:1\u20132.","journal-title":"Sci China Chem"},{"key":"4317_CR123","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/17425247.2021.18283","volume":"18","author":"J Majumder","year":"2021","unstructured":"Majumder J, Minko T. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery. Expert Opin Drug Deliv. 2021;18:205\u2013227. https:\/\/doi.org\/10.1080\/17425247.2021.18283","journal-title":"Expert Opin Drug Deliv"},{"key":"4317_CR124","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1007\/s40843-024-2903-0","volume":"67","author":"J Wang","year":"2024","unstructured":"Wang J, Huang D, Fang Y, Ren H, Zhao Y. Biomimetic cell encapsulations by microfluidics. Sci China Mater. 2024;67:2414\u201326.","journal-title":"Sci China Mater"},{"key":"4317_CR125","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s40843-023-2677-9","volume":"67","author":"J Shi","year":"2024","unstructured":"Shi J, Sun Q, Wang W, Li C, Yin H, Li H, et al. Challenges and future directions for next-generation biomedical polymersomes. Sci China Mater. 2024;67:18\u201330.","journal-title":"Sci China Mater"},{"key":"4317_CR126","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.nantod.2023.101771","volume":"49","author":"VP Chavda","year":"2023","unstructured":"Chavda VP, Pandya A, Kumar L, Raval N, Vora LK, Pulakkat S, et al. Exosome nanovesicles: A potential carrier for therapeutic delivery. Nano Today. 2023;49:101771.","journal-title":"Nano Today"},{"key":"4317_CR127","doi-asserted-by":"publisher","first-page":"11611","DOI":"10.2147\/IJN.S479697","volume":"19","author":"H Zhang","year":"2024","unstructured":"Zhang H, Xia J, Wang X, Wang Y, Chen J, He L, et al. Recent progress of exosomes in hematological malignancies: pathogenesis, diagnosis, and therapeutic strategies. Int J Nanomed. 2024;19:11611\u201331.","journal-title":"Int J Nanomed"},{"key":"4317_CR128","doi-asserted-by":"publisher","first-page":"116382","DOI":"10.1016\/j.bcp.2024.116382","volume":"226","author":"Z Deng","year":"2024","unstructured":"Deng Z, Chen Y, Xue G, Yang J, Wei X, Zhang G, et al. Mesenchymal stem cell-derived exosomes ameliorate hypoxic pulmonary hypertension by inhibiting the Hsp90aa1\/ERK\/pERK pathway. Biochem Pharmacol. 2024;226:116382.","journal-title":"Biochem Pharmacol"},{"key":"4317_CR129","doi-asserted-by":"publisher","first-page":"115816","DOI":"10.1016\/j.biopha.2023.115816","volume":"168","author":"Y Chen","year":"2023","unstructured":"Chen Y, Deng Z, Xue G, Qiang D, Juan Y, Chen G, et al. Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1\/SPP1 signaling pathway. Biomed Pharmacother. 2023;168:115816.","journal-title":"Biomed Pharmacother"},{"key":"4317_CR130","doi-asserted-by":"publisher","first-page":"24303","DOI":"10.1038\/s41598-025-09333-z","volume":"15","author":"Y Chen","year":"2025","unstructured":"Chen Y, Deng Z, She X, Gao X, Wei X, Zhang G, et al. Mesenchymal stem cell-derived exosomes improve vascular remodeling by inhibiting EGFR\/ErbB2 heterodimerization in hypoxic pulmonary hypertension. Sci Rep. 2025;15:24303.","journal-title":"Sci Rep"},{"key":"4317_CR131","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/stmcls\/sxae032","volume":"42","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Liu H, Liu C, Wang Y, Huang P, Wang X, et al. Tibetan mesenchymal stem cell-derived exosomes alleviate pulmonary vascular remodeling in hypoxic pulmonary hypertension rats. Stem Cells. 2024;42:720\u201335.","journal-title":"Stem Cells"},{"key":"4317_CR132","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s10565-024-09879-0","volume":"40","author":"R Qi","year":"2024","unstructured":"Qi R, Zhang Y, Yan F. Exosomes enriched by miR-429-3p derived from ITGB1 modified Telocytes alleviates hypoxia-induced pulmonary arterial hypertension through regulating Rac1 expression. Cell Biol Toxicol. 2024;40:32.","journal-title":"Cell Biol Toxicol"},{"key":"4317_CR133","doi-asserted-by":"publisher","first-page":"115350","DOI":"10.1016\/j.bcp.2022.115350","volume":"207","author":"N Huang","year":"2023","unstructured":"Huang N, Wang D, Zhu T, Ge X, Liu H, Yao M, et al. Plasma exosomes confer hypoxic pulmonary hypertension by transferring LOX-1 cargo to trigger phenotypic switching of pulmonary artery smooth muscle cells. Biochem Pharmacol. 2023;207:115350.","journal-title":"Biochem Pharmacol"},{"key":"4317_CR134","doi-asserted-by":"publisher","first-page":"106820","DOI":"10.1016\/j.vph.2020.106820","volume":"136","author":"S Zhang","year":"2021","unstructured":"Zhang S, Liu J, Zheng K, Chen L, Sun Y, Yao Z, et al. Exosomal miR-211 contributes to pulmonary hypertension via attenuating CaMK1\/PPAR-\u03b3axis. Vascul Pharmacol. 2021;136:106820.","journal-title":"Vascul Pharmacol"},{"key":"4317_CR135","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41419-018-1073-0","volume":"9","author":"M Zhang","year":"2018","unstructured":"Zhang M, Xin W, Ma C, Zhang H, Mao M, Liu Y, et al. Exosomal 15-LO2 mediates hypoxia-induced pulmonary artery hypertension in vivo and in vitro. Cell Death Dis. 2018;9:1022.","journal-title":"Cell Death Dis"},{"key":"4317_CR136","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.omtn.2022.06.008","volume":"29","author":"T Chen","year":"2022","unstructured":"Chen T, Sun M, Zhou Q, Guzman AM, Ramchandran R, Chen J, et al. MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen\/hypoxia-induced pulmonary hypertension in rodents. Mol Ther Nucleic Acids. 2022;29:204\u201316.","journal-title":"Mol Ther Nucleic Acids"},{"key":"4317_CR137","doi-asserted-by":"publisher","first-page":"16342","DOI":"10.1021\/acs.nanolett.4c04638","volume":"24","author":"Q Zhu","year":"2024","unstructured":"Zhu Q, Mao X, Zhu X, Xiao Y, Xu H, Su L, et al. Hypoxia-induced and glucuronic acid-modified extracellular vesicles from mesenchymal stromal cells treat pulmonary arterial hypertension by improving vascular remodeling. Nano Lett. 2024;24:16342\u201350.","journal-title":"Nano Lett"},{"key":"4317_CR138","doi-asserted-by":"publisher","first-page":"e70337","DOI":"10.1002\/mco2.70337","volume":"6","author":"Z Xu","year":"2025","unstructured":"Xu Z, Xie Y, Chen W, Deng W. Nanocarrier-based systems for targeted delivery: current challenges and future directions. MedComm. 2025;6:e70337.","journal-title":"MedComm"},{"key":"4317_CR139","doi-asserted-by":"publisher","first-page":"e2100302","DOI":"10.1002\/adhm.202100302","volume":"10","author":"K Marulanda","year":"2021","unstructured":"Marulanda K, Mercel A, Gillis DC, Sun K, Gambarian M, Roark J, et al. Intravenous delivery of lung-targeted nanofibers for pulmonary hypertension in mice. Adv Healthc Mater. 2021;10:e2100302.","journal-title":"Adv Healthc Mater"},{"key":"4317_CR140","doi-asserted-by":"publisher","first-page":"e2400113","DOI":"10.1002\/adhm.202400113","volume":"13","author":"M Li","year":"2024","unstructured":"Li M, Shang X, Lou H, Wang Z, Xiang S, Qiu Y, et al. Active anchoring stimuli-responsive nano-craft to relieve pulmonary vasoconstriction by targeting smooth muscle cell for hypoxic pulmonary hypertension treatment. Adv Healthc Mater. 2024;13:e2400113.","journal-title":"Adv Healthc Mater"},{"key":"4317_CR141","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/pharmaceutics17020224","volume":"17","author":"JS Park","year":"2025","unstructured":"Park JS, Choi YH, Min JY, Lee J, Shim G. Fundamental and targeted approaches in pulmonary arterial hypertension treatment. Pharmaceutics. 2025;17:224.","journal-title":"Pharmaceutics"},{"key":"4317_CR142","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jconrel.2014.10.029","volume":"197","author":"T Ishihara","year":"2015","unstructured":"Ishihara T, Hayashi E, Yamamoto S, Kobayashi C, Tamura Y, Sawazaki R, et al. Encapsulation of beraprost sodium in nanoparticles: analysis of sustained release properties, targeting abilities and pharmacological activities in animal models of pulmonary arterial hypertension. J Control Release. 2015;197:97\u2013104.","journal-title":"J Control Release"},{"key":"4317_CR143","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.2147\/IJN.S294626","volume":"16","author":"H Xu","year":"2021","unstructured":"Xu H, Ji H, Li Z, Qiao W, Wang C, Tang J. In vivo Pharmacokinetics and in vitro release of imatinib mesylate-loaded liposomes for pulmonary delivery. Int J Nanomed. 2021;16:1221\u20139.","journal-title":"Int J Nanomed"},{"key":"4317_CR144","doi-asserted-by":"publisher","first-page":"102524","DOI":"10.1016\/j.redox.2022.102524","volume":"58","author":"D Cai","year":"2022","unstructured":"Cai D, Chen S. Nanoparticle endothelial delivery of PGC-1\u03b1 attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling. Redox Biol. 2022;58:102524.","journal-title":"Redox Biol"},{"key":"4317_CR145","doi-asserted-by":"publisher","first-page":"8204","DOI":"10.1021\/acsnano.2c12190","volume":"17","author":"R Yuan","year":"2023","unstructured":"Yuan R, Liu M, Cheng Y, Yan F, Zhu X, Zhou S, et al. Biomimetic nanoparticle-mediated target delivery of hypoxia-responsive plasmid of angiotensin-converting enzyme 2 to reverse hypoxic pulmonary hypertension. ACS Nano. 2023;17:8204\u201322.","journal-title":"ACS Nano"},{"key":"4317_CR146","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.7150\/thno.98884","volume":"14","author":"M Chen","year":"2024","unstructured":"Chen M, Xu T, Song L, Sun T, Xu Z, Zhao Y, et al. Nanotechnology based gas delivery system: a green strategy for cancer diagnosis and treatment. Theranostics. 2024;14:5461\u201391.","journal-title":"Theranostics"},{"key":"4317_CR147","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12265-016-9684-2","volume":"9","author":"NA Mohamed","year":"2016","unstructured":"Mohamed NA, Ahmetaj-Shala B, Duluc L, Mackenzie LS, Kirkby NS, Reed DM, et al. A new NO-releasing nanoformulation for the treatment of pulmonary arterial hypertension. J Cardiovasc Transl Res. 2016;9:162\u20134.","journal-title":"J Cardiovasc Transl Res"},{"key":"4317_CR148","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1016\/j.biomaterials.2014.02.009","volume":"35","author":"X Liu","year":"2014","unstructured":"Liu X, Wang G, You Z, Qian P, Chen H, Dou Y, et al. Inhibition of hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by a mTOR siRNA-loaded cyclodextrin nanovector. Biomaterials. 2014;35:4401\u201316.","journal-title":"Biomaterials"},{"key":"4317_CR149","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1007\/s11426-024-2176-7","volume":"67","author":"Q Ding","year":"2024","unstructured":"Ding Q, Zhang S, Kim JS. A lysosomal-targeted Pt(II) metallacycle for NIR-II fluorescence imaging guided highly efficient tumor immunogenic cell death. Sci China Chem. 2024;67:3508\u20139.","journal-title":"Sci China Chem"},{"key":"4317_CR150","doi-asserted-by":"publisher","first-page":"e2212102","DOI":"10.1002\/adma.202212102","volume":"35","author":"Y Song","year":"2023","unstructured":"Song Y, You Q, Chen X. Transition metal-based therapies for inflammatory diseases. Adv Mater. 2023;35:e2212102.","journal-title":"Adv Mater"},{"key":"4317_CR151","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1049\/nbt2.12138","volume":"17","author":"Z Hua","year":"2023","unstructured":"Hua Z, Han M, Song L, Yan Y, Chen H, Wang J, et al. Inhibition of pulmonary artery smooth muscle cells via the delivery of curcuminoid WZ35 by Cu-based metal organic frameworks. IET Nanobiotechnol. 2023;17:420\u20134.","journal-title":"IET Nanobiotechnol"},{"key":"4317_CR152","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s12951-024-02738-4","volume":"22","author":"R Xiao","year":"2024","unstructured":"Xiao R, Liu J, Shi L, Zhang T, Liu J, Qiu S, et al. Au-modified ceria nanozyme prevents and treats hypoxia-induced pulmonary hypertension with greatly improved enzymatic activity and safety. J Nanobiotechnol. 2024;22:492.","journal-title":"J Nanobiotechnol"},{"key":"4317_CR153","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1038\/s41598-021-83423-6","volume":"11","author":"NA Mohamed","year":"2021","unstructured":"Mohamed NA, Abou-Saleh H, Kameno Y, Marei I, de Nucci G, Ahmetaj-Shala B, et al. Studies on metal-organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension. Sci Rep. 2021;11:4336.","journal-title":"Sci Rep"},{"key":"4317_CR154","doi-asserted-by":"publisher","first-page":"13213","DOI":"10.1021\/acsanm.5c01210","volume":"8","author":"X Chen","year":"2025","unstructured":"Chen X, Wang L, Yang Y, Mai Q, Cai Q, Zhou Y, et al. Thiolated nanovesicles integrating mucolytics for efficient lung mucus penetration and acute lung injury therapy. ACS Appl Nano Mater. 2025;8:13213\u201326.","journal-title":"ACS Appl Nano Mater"},{"key":"4317_CR155","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1186\/s12967-025-06649-2","volume":"23","author":"X Li","year":"2025","unstructured":"Li X, Tang Z, Kuang L, Wu Y, Huang X. Platelet membrane-coated nanoparticles inhibit platelet activation and neutrophil extracellular traps formation in acute lung injury. J Transl Med. 2025;23:841.","journal-title":"J Transl Med"},{"key":"4317_CR156","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1161\/HYPERTENSIONAHA.110.157032","volume":"57","author":"L Chen","year":"2011","unstructured":"Chen L, Nakano K, Kimura S, Matoba T, Iwata E, Miyagawa M, et al. Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertension. Hypertension. 2011;57:343\u201350.","journal-title":"Hypertension"},{"key":"4317_CR157","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.108.121418","volume":"53","author":"S Kimura","year":"2009","unstructured":"Kimura S, Egashira K, Chen L, Nakano K, Iwata E, Miyagawa M, et al. Nanoparticle-mediated delivery of nuclear factor \u03baB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension. Hypertension. 2009;53:877\u201383.","journal-title":"Hypertension"},{"key":"4317_CR158","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/2045893217710224","volume":"7","author":"NA Mohamed","year":"2017","unstructured":"Mohamed NA, Davies RP, Lickiss PD, Ahmetaj-Shala B, Reed DM, Gashaw HH, et al. Chemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapy. Pulm Circ. 2017;7:643\u201353.","journal-title":"Pulm Circ"},{"key":"4317_CR159","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/IJN.S436271","volume":"19","author":"R Wang","year":"2024","unstructured":"Wang R, Li Q, Wu P, Ren K, Li Y, Wang Y, et al. Fe-capsaicin nanozymes attenuate sepsis-induced acute lung injury via NF-\u03baB signaling. Int J Nanomed. 2024;19:73\u201390.","journal-title":"Int J Nanomed"},{"key":"4317_CR160","doi-asserted-by":"publisher","first-page":"e2203432","DOI":"10.1002\/smll.202203432","volume":"18","author":"K Wang","year":"2022","unstructured":"Wang K, Rong G, Gao Y, Wang M, Sun J, Sun H, et al. Fluorous-tagged peptide nanoparticles ameliorate acute lung injury via lysosomal stabilization and inflammation inhibition in pulmonary macrophages. Small. 2022;18:e2203432.","journal-title":"Small"},{"key":"4317_CR161","doi-asserted-by":"publisher","first-page":"100799","DOI":"10.1016\/j.jlr.2025.100799","volume":"66","author":"Y Li","year":"2025","unstructured":"Li Y, Li H, Hu Z, Zhang Y, Ding X, Huang X, et al. Phosphatidylserine-decorated delivery platform helps alleviate acute lung injury via potentiating macrophage targeting. J Lipid Res. 2025;66:100799.","journal-title":"J Lipid Res"},{"key":"4317_CR162","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1186\/s13287-025-04722-7","volume":"16","author":"K Shen","year":"2025","unstructured":"Shen K, Wang P, Zhang H, Wang X, Fu H, Li J, et al. MiR-24-3p delivered by adipose derived stem cells exosomes alleviate macrophage pyroptosis via NLRP3\/Caspase1\/GSDMD in sepsis ALI. Stem Cell Res Ther. 2025;16:582.","journal-title":"Stem Cell Res Ther"},{"key":"4317_CR163","doi-asserted-by":"publisher","first-page":"160171","DOI":"10.1016\/j.cej.2025.160171","volume":"506","author":"P Pang","year":"2025","unstructured":"Pang P, Liu W, Ma S, Liu J, Wu S, Xue W, et al. Self-assembling natural flavonoid nanomedicines for alveolar macrophage reprogramming by restoring mitochondrial function in acute lung injury therapy. Chem Eng J. 2025;506:160171.","journal-title":"Chem Eng J"},{"key":"4317_CR164","doi-asserted-by":"publisher","first-page":"e10848","DOI":"10.1002\/adfm.202510848","volume":"35","author":"F Pan","year":"2025","unstructured":"Pan F, Guo Z, Li B, Zhang Q, Liu N, Wu Z, et al. Inhalable lipid nanoparticles with mucus clearance and ros scavenging properties for acute lung injury treatment. Adv Funct Mater. 2025;35:e10848.","journal-title":"Adv Funct Mater"},{"key":"4317_CR165","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s12015-025-10976-8","volume":"22","author":"X Wang","year":"2025","unstructured":"Wang X, Meng L, Wang Q, Rong R, Zhang Y, Zhao X, et al. Investigating the therapeutic efficacy of quality-controlled, miR-146a-5p-enriched small extracellular vesicles derived from MSCs against idiopathic pulmonary fibrosis. Stem Cell Rev Rep. 2025;22:523\u201344.","journal-title":"Stem Cell Rev Rep"},{"key":"4317_CR166","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1093\/jimmun\/vkaf097","volume":"214","author":"J Yang","year":"2025","unstructured":"Yang J, Yin X, Zhang T. miR-124-3p derived from plasma exosomes enhances M2 macrophage polarization to treat acute lung injury. J Immunol. 2025;214:2281\u201397.","journal-title":"J Immunol"},{"key":"4317_CR167","doi-asserted-by":"publisher","first-page":"13003","DOI":"10.1021\/acs.nanolett.5c03271","volume":"25","author":"X Lin","year":"2025","unstructured":"Lin X, Meng Q, Pan Y, Hu X, Dong Z, Wang J, et al. Inhalable macrophage membrane-camouflaged hyperbranched polymeric nanoparticles for acute lung injury treatment. Nano Lett. 2025;25:13003\u201313.","journal-title":"Nano Lett"},{"key":"4317_CR168","doi-asserted-by":"publisher","first-page":"115072","DOI":"10.1016\/j.matdes.2025.115072","volume":"260","author":"Y Xu","year":"2025","unstructured":"Xu Y, Fu J, Lan Q, Zhang J, Yuan H, Yang Y, et al. Targeted metabolic reprogramming with lactate-scavenging CeO2@PLP nanoparticles attenuates pulmonary fibrosis via dual modulation of macrophage polarization and fibroblast activation. Mater Design. 2025;260:115072.","journal-title":"Mater Design"},{"key":"4317_CR169","doi-asserted-by":"publisher","first-page":"114413","DOI":"10.1016\/j.jconrel.2025.114413","volume":"389","author":"B Tan","year":"2026","unstructured":"Tan B, Yang W, Zhang G, Zeng R. Apoptotic-body-inspired nanoplatform targeting the lung-macrophage-mitochondrial axis for acute lung injury therapy. J Control Release. 2026;389:114413.","journal-title":"J Control Release"},{"key":"4317_CR170","doi-asserted-by":"publisher","first-page":"0663","DOI":"10.34133\/research.0663","volume":"8","author":"J Zhuang","year":"2025","unstructured":"Zhuang J, Hai Y, Lu X, Sun B, Fan R, Zhang B, et al. A self-assembled metabolic regulator reprograms macrophages to combat cytokine storm and boost sepsis immunotherapy. Research. 2025;8:0663.","journal-title":"Research"},{"key":"4317_CR171","doi-asserted-by":"publisher","first-page":"e2503574122","DOI":"10.1073\/pnas.2503574122","volume":"122","author":"Q Ding","year":"2025","unstructured":"Ding Q, Liu J, Wang Y, Kim J, Huang Z, Lee Y, et al. Dual-laser 808 and 1,064 nm strategy that circumvents the Achilles\u2019 heel of photothermal therapy. Proc Natl Acad Sci U S A. 2025;122:e2503574122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4317_CR172","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejps.2018.10.003","volume":"125","author":"N Nafee","year":"2018","unstructured":"Nafee N, Makled S, Boraie N. Nanostructured lipid carriers versus solid lipid nanoparticles for the potential treatment of pulmonary hypertension via nebulization. Eur J Pharm Sci. 2018;125:151\u201362.","journal-title":"Eur J Pharm Sci"},{"key":"4317_CR173","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.3390\/pharmaceutics15072011","volume":"15","author":"M Abudurexiti","year":"2023","unstructured":"Abudurexiti M, Zhao Y, Wang X, Han L, Liu T, Wang C, et al. Bio-Inspired nanocarriers derived from stem cells and their extracellular vesicles for targeted drug delivery. Pharmaceutics. 2023;15:2011.","journal-title":"Pharmaceutics"},{"key":"4317_CR174","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1161\/CIRCULATIONAHA.112.114173","volume":"126","author":"C Lee","year":"2012","unstructured":"Lee C, Mitsialis SA, Aslam M, Vitali SH, Vergadi E, Konstantinou G, et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation. 2012;126:2601\u201311.","journal-title":"Circulation"},{"key":"4317_CR175","doi-asserted-by":"publisher","first-page":"13525","DOI":"10.2147\/IJN.S493047","volume":"19","author":"Y Liu","year":"2024","unstructured":"Liu Y, He C, Zhong Q, Shi X, Li H, Fu G, et al. Tadalafil enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in pulmonary hypertension by upregulating miR-29a-3p. Int J Nanomed. 2024;19:13525\u201346.","journal-title":"Int J Nanomed"},{"key":"4317_CR176","first-page":"33","volume":"76","author":"H Liu","year":"2024","unstructured":"Liu H, Zhang Y, Zhang Q, Wang Y, Ge R, Ma L. Effects of human umbilical cord mesenchymal stem cells (MSCs)-derived exosomes on pulmonary vascular remodeling in hypoxic pulmonary hypertension. Acta Physiol Sinica. 2024;76:33\u201344.","journal-title":"Acta Physiol Sinica"},{"key":"4317_CR177","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/stmcls\/sxad098","volume":"42","author":"H Liu","year":"2024","unstructured":"Liu H, Zhang Q, Liu C, Zhang Y, Wang Y, Huang P, et al. Human umbilical cord mesenchymal stromal cell-derived exosomes alleviate hypoxia-induced pulmonary arterial hypertension in mice via macrophages. Stem Cells. 2024;42:329\u201345.","journal-title":"Stem Cells"},{"key":"4317_CR178","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41569-023-00924-9","volume":"21","author":"JP Richalet","year":"2024","unstructured":"Richalet JP, Hermand E, Lhuissier FJ. Cardiovascular physiology and pathophysiology at high altitude. Nat Rev Cardiol. 2024;21:75\u201388.","journal-title":"Nat Rev Cardiol"},{"key":"4317_CR179","doi-asserted-by":"publisher","first-page":"155529","DOI":"10.1016\/j.phymed.2024.155529","volume":"128","author":"Y Hou","year":"2024","unstructured":"Hou Y, Fan F, Xie N, Zhang Y, Wang X, Meng X. Rhodiola crenulata alleviates hypobaric hypoxia-induced brain injury by maintaining BBB integrity and balancing energy metabolism dysfunction. Phytomedicine. 2024;128:155529.","journal-title":"Phytomedicine"},{"key":"4317_CR180","doi-asserted-by":"publisher","first-page":"154568","DOI":"10.1016\/j.phymed.2022.154568","volume":"109","author":"Y Hou","year":"2023","unstructured":"Hou Y, Zhang Y, Jiang S, Xie N, Zhang Y, Meng X, et al. Salidroside intensifies mitochondrial function of CoCl2-damaged HT22 cells by stimulating PI3K-AKT-MAPK signaling pathway. Phytomedicine. 2023;109:154568.","journal-title":"Phytomedicine"},{"key":"4317_CR181","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/intimm\/dxs110","volume":"25","author":"E Riboldi","year":"2013","unstructured":"Riboldi E, Porta C, Morlacchi S, Viola A, Mantovani A, Sica A. Hypoxia-mediated regulation of macrophage functions in pathophysiology. Int Immunol. 2013;25:67\u201375.","journal-title":"Int Immunol"},{"key":"4317_CR182","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12931-025-03364-w","volume":"26","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Cai Z, Bai M, Wu X, Wang W, Liu R, et al. Harnessing NLRX1: a new frontier in mitigating inflammation in pulmonary hypertension. Respir Res. 2025;26:311.","journal-title":"Respir Res"},{"key":"4317_CR183","doi-asserted-by":"publisher","first-page":"L885","DOI":"10.1152\/ajplung.00399.2024","volume":"328","author":"CV Lewis","year":"2025","unstructured":"Lewis CV, Nguyen TN, Porfilio TE, Burciaga SD, Posey JN, Jordan M, et al. Vascular EC-SOD limits the accumulation, proinflammatory profibrotic reprogramming, and hyaluronan binding of interstitial macrophages in hypoxia. Am J Physiol Lung Cell Mol Physiol. 2025;328:L885\u2013900.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4317_CR184","doi-asserted-by":"publisher","first-page":"e2314747121","DOI":"10.1073\/pnas.2314747121","volume":"121","author":"G Zhao","year":"2024","unstructured":"Zhao G, Xue L, Geisler HC, Xu J, Li X, Mitchell MJ, et al. Precision treatment of viral pneumonia through macrophage-targeted lipid nanoparticle delivery. Proc Natl Acad Sci U S A. 2024;121:e2314747121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4317_CR185","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12931-023-02474-7","volume":"24","author":"M Wan","year":"2023","unstructured":"Wan M, Lu C, Liu Y, Luo F, Zhou J, Xu F. Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanism. Respir Res. 2023;24:233.","journal-title":"Respir Res"},{"key":"4317_CR186","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1007\/s11426-024-2029-7","volume":"67","author":"J Lin","year":"2024","unstructured":"Lin J, Ding Q, Sun Y. A noval iron-capturing nanocomposites against biofilms for disrupting bacterial nutritional balance. Sci China Chem. 2024;67:1760\u20131.","journal-title":"Sci China Chem"},{"key":"4317_CR187","doi-asserted-by":"publisher","first-page":"e17167","DOI":"10.1016\/j.heliyon.2023.e17167","volume":"9","author":"B Qiu","year":"2023","unstructured":"Qiu B, Yuan P, Du X, Jin H, Du J, Huang Y. Hypoxia inducible factor-1\u03b1 is an important regulator of macrophage biology. Heliyon. 2023;9:e17167.","journal-title":"Heliyon"},{"key":"4317_CR188","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41581-022-00587-8","volume":"18","author":"CT Taylor","year":"2022","unstructured":"Taylor CT, Scholz CC. The effect of HIF on metabolism and immunity. Nat Rev Nephrol. 2022;18:573\u201387.","journal-title":"Nat Rev Nephrol"},{"key":"4317_CR189","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1165\/rcmb.2024-0353OC","volume":"73","author":"A Czerwinski","year":"2025","unstructured":"Czerwinski A, Sidlowski P, Mooers E, Liu Y, Teng R, Pritchard K Jr., et al. Stub1 acetylation by CBP\/p300 attenuates chronic hypoxic-driven pulmonary hypertension by suppressing HIF-2\u03b1. Am J Respir Cell Mol Biol. 2025;73:369\u201382.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4317_CR190","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.2147\/IJN.S456533","volume":"19","author":"J Luo","year":"2024","unstructured":"Luo J, Wang H, Chen J, Wei X, Feng J, Zhang Y, et al. The application of drugs and nano-therapies targeting immune cells in hypoxic inflammation. Int J Nanomed. 2024;19:3441\u201359.","journal-title":"Int J Nanomed"},{"key":"4317_CR191","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2014.11.023","volume":"159","author":"D Gosselin","year":"2014","unstructured":"Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell. 2014;159:1327\u201340.","journal-title":"Cell"},{"key":"4317_CR192","doi-asserted-by":"publisher","first-page":"L229","DOI":"10.1152\/ajplung.00238.2014","volume":"308","author":"SC Pugliese","year":"2015","unstructured":"Pugliese SC, Poth JM, Fini MA, Olschewski A, El Kasmi KC, Stenmark KR. The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes. Am J Physiol Lung Cell Mol Physiol. 2015;308:L229\u201352.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4317_CR193","doi-asserted-by":"publisher","first-page":"e1222","DOI":"10.1002\/cti2.1222","volume":"9","author":"G Sreejit","year":"2020","unstructured":"Sreejit G, Fleetwood AJ, Murphy AJ, Nagareddy PR. Origins and diversity of macrophages in health and disease. Clin Transl Immunol. 2020;9:e1222.","journal-title":"Clin Transl Immunol"},{"key":"4317_CR194","doi-asserted-by":"publisher","first-page":"112635","DOI":"10.1016\/j.isci.2025.112635","volume":"28","author":"SA Habash","year":"2025","unstructured":"Habash SA, Takahashi N, Eltalkhawy YM, Abdelnaser RA, Ogata-Aoki H, Okada S, et al. Macrophages with different origins proliferate ex vivo and do not lose their core intrinsic features. iScience. 2025;28:112635.","journal-title":"iScience"},{"key":"4317_CR195","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.2147\/IJN.S444470","volume":"19","author":"C Zeng","year":"2024","unstructured":"Zeng C, Wang Q, Liu X, Wang K, Wang C, Ju X, et al. Localized administration of Bcar3 siRNA via nano-self-assembly to treat idiopathic pulmonary fibrosis by disrupting macrophage-fibroblast crosstalk. Int J Nanomed. 2024;19:1827\u201342.","journal-title":"Int J Nanomed"},{"key":"4317_CR196","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/imm.13154","volume":"160","author":"E Evren","year":"2020","unstructured":"Evren E, Ringqvist E, Willinger T. Origin and ontogeny of lung macrophages: from mice to humans. Immunology. 2020;160:126\u201338.","journal-title":"Immunology"},{"key":"4317_CR197","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1161\/CIRCRESAHA.125.326173","volume":"137","author":"F Qiu","year":"2025","unstructured":"Qiu F, Miao H, Hui H, Qiu L, Chen Y, Luo M, et al. MHCII(hi)LYVE1(lo)CCR2(hi) interstitial macrophages promote medial fibrosis in pulmonary arterioles and contribute to pulmonary hypertension. Circ Res. 2025;137:46\u201366.","journal-title":"Circ Res"},{"key":"4317_CR198","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/CIRCRESAHA.123.323679","volume":"135","author":"S Zafeiropoulos","year":"2024","unstructured":"Zafeiropoulos S, Ahmed U, Bekiaridou A, Jayaprakash N, Mughrabi IT, Saleknezhad N, et al. Ultrasound neuromodulation of an anti-inflammatory pathway at the spleen improves experimental pulmonary hypertension. Circ Res. 2024;135:41\u201356.","journal-title":"Circ Res"},{"key":"4317_CR199","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.freeradbiomed.2025.11.038","volume":"244","author":"L Ou","year":"2025","unstructured":"Ou L, Chen Y, Shen A, He S, Mei J, Meng Z, et al. Epigenetically activated MIR100HG regulates UPF1-mediated oxidative stress to promote pulmonary vascular immune microenvironment remodeling. Free Radic Biol Med. 2025;244:210\u201328.","journal-title":"Free Radic Biol Med"},{"key":"4317_CR200","doi-asserted-by":"publisher","first-page":"12262","DOI":"10.1021\/acsnano.2c03075","volume":"16","author":"H Chung","year":"2022","unstructured":"Chung H, Park JY, Kim K, Yoo RJ, Suh M, Gu GJ, et al. Circulation time-optimized albumin nanoplatform for quantitative visualization of lung metastasis via targeting of macrophages. ACS Nano. 2022;16:12262\u201375.","journal-title":"ACS Nano"},{"key":"4317_CR201","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/17425247.2024.2375400","volume":"21","author":"Y He","year":"2024","unstructured":"He Y, Wang Y, Wang L, Jiang W, Wilhelm S. Understanding nanoparticle-liver interactions in nanomedicine. Expert Opin Drug Deliv. 2024;21:829\u201343.","journal-title":"Expert Opin Drug Deliv"},{"key":"4317_CR202","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1021\/mp800032f","volume":"5","author":"MA Dobrovolskaia","year":"2008","unstructured":"Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm. 2008;5:487\u201395.","journal-title":"Mol Pharm"},{"key":"4317_CR203","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nnano.2007.223","volume":"2","author":"MA Dobrovolskaia","year":"2007","unstructured":"Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nat Nanotechnol. 2007;2:469\u201378.","journal-title":"Nat Nanotechnol"},{"key":"4317_CR204","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.2147\/DDDT.S282368","volume":"14","author":"M Zhang","year":"2020","unstructured":"Zhang M, Du Y, Wang S, Chen B. A review of biomimetic nanoparticle drug delivery systems based on cell membranes. Drug Des Devel Ther. 2020;14:5495\u2013503.","journal-title":"Drug Des Devel Ther"},{"key":"4317_CR205","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s42114-025-01362-6","volume":"8","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Xu H, Wu J, Sun T, Lu H, Wang S, et al. A hierarchically assembled oral formulation with drug-convertible carriers for targeted ulcerative colitis therapy through a three-pronged strategy. Adv Compos Hybrid Mater. 2025;8:280.","journal-title":"Adv Compos Hybrid Mater"},{"key":"4317_CR206","doi-asserted-by":"publisher","first-page":"16661","DOI":"10.1021\/jacs.5c04975","volume":"147","author":"Q Ding","year":"2025","unstructured":"Ding Q, Wang C, Wang H, Xiang C, Wang Z, Wang Y, et al. Rabies virus targeting NIR-II phototheranostics. J Am Chem Soc. 2025;147:16661\u201373.","journal-title":"J Am Chem Soc"},{"key":"4317_CR207","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s40843-024-3187-8","volume":"68","author":"T Zhou","year":"2025","unstructured":"Zhou T, Li Z. Harnessing NIR-II luminescence in ultrasmall gold nanoparticles for enhanced biomedical applications. Sci China Mater. 2025;68:86\u2013104.","journal-title":"Sci China Mater"},{"key":"4317_CR208","doi-asserted-by":"publisher","first-page":"e2420359","DOI":"10.1002\/adma.202420359","volume":"37","author":"Q Ding","year":"2025","unstructured":"Ding Q, Huang S, Zhang Z, Yu D, Li M, He Q, et al. Integration of photodiagnosis and therapy guided by micro\/nanorobots. Adv Mater. 2025;37:e2420359.","journal-title":"Adv Mater"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04317-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04317-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04317-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:05:33Z","timestamp":1778720733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04317-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":208,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4317"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04317-1","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have provided consent for the manuscript to be published in Journal of Nanobiotechnology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"438"}}